デフォルト表紙
市場調査レポート
商品コード
1605781

臨床リスクグルーピングソリューション市場:コンポーネント別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年~2032年

Clinical Risk Grouping Solution Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 269 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.81円
臨床リスクグルーピングソリューション市場:コンポーネント別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年~2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

臨床リスクグルーピングソリューション市場は、2023年に7億490万米ドルと評価され、2024年から2032年にかけて14.10%のCAGRで拡大しました。

臨床リスクグルーピングソリューション市場 - 市場力学

効率的な集団健康管理に対するニーズの高まりと電子カルテ(EHR)の利用拡大が相まって、市場の成長を促進すると予測されます。

集団健康管理(PHM)は、さまざまな健康決定要因に対処することによって、個人の集団の健康アウトカムを改善することに焦点を当てています。EHRシステムの普及により、患者データは一元化され、アクセスしやすくなっています。臨床リスクグルーピングソリューションは、このデータを活用して患者のリスクを包括的に評価し、医療従事者が効果的な意思決定を行うために必要な情報を確実に入手できるようにします。米国病院協会によると、2021年時点で、勤務医のほぼ5人に4人(78%)、連邦政府以外の急性期病院のほぼすべて(96%)が認定EHRを採用しています。さらに、新興国では医療提供を改善するためにデジタルヘルスソリューションの導入が進んでおり、大きな市場機会をもたらしています。しかし、データのプライバシーとセキュリティに関する懸念が市場成長の妨げになる可能性があります。

臨床リスクグルーピングソリューション市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024年~2032年)に約14.10%のCAGRで毎年成長すると予測されています。

コンポーネント別では、ソフトウェアが2023年に最大の市場シェアを示すと予測されました。

用途別では、ポピュレーションヘルスマネジメントが2023年の主要コンポーネントでした。

エンドユーザー別では、2023年には病院・診療所部門が主要コンポーネントでした。

地域別では、北米が2023年の主要収益源でした。

臨床リスクグルーピングソリューション市場 - セグメンテーション分析:

世界の臨床リスクグルーピングソリューション市場は、コンポーネント、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はコンポーネントによって、ソフトウェアとサービスに区分されます。ソフトウェア部門が市場で圧倒的な地位を占めています。臨床リスクグルーピングソリューション市場は、ヘルスケア機関におけるクリニカルリスクの評価と管理を目的としたソフトウェアソリューションが中心です。

市場は用途によって、ポピュレーションヘルス管理、慢性疾患管理、臨床意思決定支援、不正検知・防止、その他に分類されます。ポピュレーションヘルス管理は市場の主要セグメントです。医療提供者が患者ケアの向上と集団の健康状態の効果的な管理を目指す中、臨床リスクグルーピングソリューション市場は、集団健康管理との連携が進んでいます。

市場はエンドユーザー別に、病院・診療所、外来手術センター、長期ケアセンター、その他に分類されます。病院・診療所分野が市場成長の主な促進要因です。この分野は、効果的なリスク評価と管理を通じて患者の安全性を向上させ、臨床ケアを最適化することに重点を置いているため、拡大を経験しています。

臨床リスクグルーピングソリューション市場 - 地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカと地理的に広範囲に及んでいます。これらの地域は、事業活動に貢献している国に基づいてさらに区分されます。北米は、主にヘルスケアITインフラへの投資の増加により、市場拡大をリードしています。米国政府は、医療提供者に電子カルテ(EHR)やその他の医療ITソリューションの導入を奨励するHITECH法など、ヘルスケアITシステム改善のためのイニシアチブをいくつか実施しています。この重点的な取り組みにより、臨床リスクグルーピングソリューションなどの先端技術に多額の投資が行われています。2021年、米国は国内総生産(GDP)の17.8%をヘルスケアに割り当て、OECD諸国の平均支出のほぼ2倍を記録しました。欧州は、慢性疾患に対する意識の高まりに牽引され、市場成長率第2位の地域となっています。

臨床リスクグルーピングソリューション市場 - 競合情勢:

臨床リスクグルーピングソリューション市場は競争が激化しており、多数の参入企業が医療提供者の要件に合わせた最先端のソリューションの提供を目指しています。各社はリスクグルーピングソリューションの予測機能を向上させるため、人工知能や機械学習などの先端技術に多大な投資を行っています。このような技術革新は、競争力を維持するために不可欠です。ヘルスケアの情勢が変貌を続ける中、イノベーション、相互運用性、規制状況を重視しながら、病院やクリニックの要求に効果的に対応する企業は、成功に向けて最適なポジションを確保できると思われます。

目次

第1章 臨床リスクグルーピングソリューション市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 臨床リスクグルーピングソリューションの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 臨床リスクグルーピングソリューション業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 臨床リスクグルーピングソリューション市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 臨床リスクグルーピングソリューション市場情勢

  • 臨床リスクグルーピングソリューションの市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 臨床リスクグルーピングソリューション市場 - コンポーネント別

  • 概要
    • セグメントシェア分析 - コンポーネント別
    • ソフトウェア
      • プライベートクラウド
      • パブリッククラウド
      • ハイブリッドクラウド
    • サービス

第8章 臨床リスクグルーピングソリューション市場 - 用途別

  • 概要
    • セグメントシェア分析 - 用途別
    • ポピュレーションヘルス管理
    • 慢性疾患の管理
    • 臨床意思決定支援
    • 不正行為の検出と防止
    • その他

第9章 臨床リスクグルーピングソリューション市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析 - エンドユーザー別
    • 病院・診療所
    • 外来手術センター
    • 長期ケアセンター
    • その他

第10章 臨床リスクグルーピングソリューション市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 臨床リスクグルーピングソリューション業界

  • 競合ダッシュボード
  • 企業プロファイル
    • 3M Corporation
    • 4S Dawn Clinical Software
    • Apixio
    • Cotiviti Inc.
    • Evolent
    • HBI Solutions
    • Health Catalyst, Inc.
    • HealthEC LLC
    • Lightbeam Health Solutions
    • MedeAnalytics, Inc.
    • Nuance Communications, Inc.
    • Optum, Inc.
    • RELX(LexisNexis Risk Solution)
    • ZeOmega
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV4190

REPORT HIGHLIGHT

The Clinical Risk Grouping Solution Market was valued at USD 704.90 million in 2023 and expanded at a CAGR of 14.10% from 2024 to 2032.

A Clinical Risk Grouping Solution represents a structured methodology employed in the healthcare sector to classify patients according to their clinical risks and requirements. This approach assists healthcare professionals in stratifying patients, thereby improving management, resource distribution, and the overall delivery of care. Such solutions are frequently utilized across diverse healthcare environments, including hospitals, managed care organizations, and public health programs, to optimize patient care and enhance operational effectiveness.

Clinical Risk Grouping Solution Market- Market Dynamics

The increasing need for efficient population health management, coupled with the expanding utilization of electronic health records (EHR), is anticipated to propel market growth.

Population health management (PHM) focuses on improving the health outcomes of groups of individuals by addressing various health determinants. The widespread adoption of EHR systems has resulted in centralized and accessible patient data. Clinical Risk Grouping Solutions leverage this data to conduct comprehensive assessments of patient risks, ensuring that healthcare providers have the information needed for effective decision-making. According to the American Hospital Association, as of 2021, nearly 4 in 5 office-based physicians (78%) and nearly all non-federal acute care hospitals (96%) adopted a certified EHR. Furthermore, Emerging economies are increasingly adopting digital health solutions to improve healthcare delivery, which presents significant market opportunities. However, Data Privacy and Security Concerns may hampers the market growth.

Clinical Risk Grouping Solution Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.10% over the forecast period (2024-2032)

Based on Component segmentation, software was predicted to show maximum market share in the year 2023

Based on Application segmentation, Population Health Management was the leading Component in 2023

Based on End-User segmentation, Hospitals, and clinics sector was the leading Component in 2023

Based on region, North America was the leading revenue generator in 2023

Clinical Risk Grouping Solution Market- Segmentation Analysis:

The Global Clinical Risk Grouping Solution Market is segmented based on Component, Application, End-User, and Region.

The market is segmented into three categories according to components: software and services. The software segment holds a dominant position in the market. The Clinical Risk Grouping Solution market is centered on software solutions aimed at evaluating and managing clinical risk within healthcare organizations.

The market is categorized into two segments based on application: Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Population Health Management is the leading segment within the market. The Clinical Risk Grouping Solution market is progressively aligning with Population Health Management as healthcare providers aim to improve patient care and effectively manage population health.

The market is classified into two primary categories according to End-User: Hospitals and clinics, Ambulatory surgical centers, Long-term care centers, and others. The Hospitals and clinics sector is the primary driver of market growth. This sector is experiencing expansion as it emphasizes improving patient safety and optimizing clinical care through effective risk assessment and management.

Clinical Risk Grouping Solution Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads in market expansion, primarily due to increased investments in healthcare IT infrastructure. The U.S. government has implemented several initiatives to improve healthcare IT systems, including the HITECH Act, which encourages healthcare providers to adopt electronic health records (EHRs) and other health IT solutions. This emphasis has resulted in substantial investments in advanced technologies, such as Clinical Risk Grouping Solutions. In 2021, the United States allocated 17.8 percent of its gross domestic product (GDP) to healthcare, nearly double the average expenditure of OECD countries. Europe ranks as the second largest region for market growth, driven by a rising awareness of chronic diseases.

Clinical Risk Grouping Solution Market- Competitive Landscape:

The market for Clinical Risk Grouping Solutions is becoming progressively competitive, with a multitude of participants aiming to deliver cutting-edge solutions tailored to the requirements of healthcare providers. Organizations are making significant investments in advanced technologies, including artificial intelligence and machine learning, to improve the predictive functionalities of their risk grouping offerings. Such innovation is essential for sustaining a competitive edge. As the healthcare landscape continues to transform, those companies that emphasize innovation, interoperability, and regulatory compliance while effectively addressing the demands of hospitals and clinics will be optimally positioned for success.

Recent Developments:

On April 1, 2021, 3M Health Information Systems launched an innovative technology platform designed to enable healthcare providers and payers to focus on care prioritization and resource allocation for individuals and patient groups identified as high-risk.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Corporation
  • 4S Dawn Clinical Software
  • Apixio
  • Cotiviti Inc.
  • Evolent
  • HBI Solutions
  • Health Catalyst, Inc.
  • HealthEC LLC
  • Lightbeam Health Solutions
  • MedeAnalytics, Inc.
  • Nuance Communications, Inc.
  • Optum, Inc.
  • RELX (LexisNexis Risk Solution)
  • ZeOmega
  • Others

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Private Cloud
  • Public Cloud
  • Hybrid Cloud
  • Services

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Population health management
  • Chronic disease management
  • Clinical decision support
  • Fraud detection and prevention
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & clinics
  • Ambulatory surgical centers
  • Long-term care centers
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Risk Grouping Solution Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Risk Grouping Solution Market Snippet by Component
    • 2.1.2. Clinical Risk Grouping Solution Market Snippet by Application
    • 2.1.3. Clinical Risk Grouping Solution Market Snippet by End-User
    • 2.1.4. Clinical Risk Grouping Solution Market Snippet by Country
    • 2.1.5. Clinical Risk Grouping Solution Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Risk Grouping Solution Key Market Trends

  • 3.1. Clinical Risk Grouping Solution Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Risk Grouping Solution Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Risk Grouping Solution Market Opportunities
  • 3.4. Clinical Risk Grouping Solution Market Future Trends

4. Clinical Risk Grouping Solution Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Risk Grouping Solution Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Risk Grouping Solution Market Landscape

  • 6.1. Clinical Risk Grouping Solution Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Risk Grouping Solution Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
      • 7.1.2.1. Private Cloud
      • 7.1.2.2. Public Cloud
      • 7.1.2.3. Hybrid Cloud
    • 7.1.3. Services

8. Clinical Risk Grouping Solution Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Population health management
    • 8.1.3. Chronic disease management
    • 8.1.4. Clinical decision support
    • 8.1.5. Fraud detection and prevention
    • 8.1.6. Other

9. Clinical Risk Grouping Solution Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Long term care centers
    • 9.1.5. Other

10. Clinical Risk Grouping Solution Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Clinical Risk Grouping Solution Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Clinical Risk Grouping Solution Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Clinical Risk Grouping Solution Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Clinical Risk Grouping Solution Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Clinical Risk Grouping Solution Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Clinical Risk Grouping Solution Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 3M Corporation
    • 11.2.2. 4S Dawn Clinical Software
    • 11.2.3. Apixio
    • 11.2.4. Cotiviti Inc.
    • 11.2.5. Evolent
    • 11.2.6. HBI Solutions
    • 11.2.7. Health Catalyst, Inc.
    • 11.2.8. HealthEC LLC
    • 11.2.9. Lightbeam Health Solutions
    • 11.2.10. MedeAnalytics, Inc.
    • 11.2.11. Nuance Communications, Inc.
    • 11.2.12. Optum, Inc.
    • 11.2.13. RELX (LexisNexis Risk Solution)
    • 11.2.14. ZeOmega
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us